Development and Validation of a Risk Score for Predicting ICU Admission in Adults with New-Onset Encephalitis.
Clinical prediction rules
Critical care outcomes
Encephalitis
Prognosis
Risk assessment
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
received:
01
03
2024
accepted:
02
07
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
31
7
2024
Statut:
aheadofprint
Résumé
Timely intensive care unit (ICU) admission for patients with encephalitis is associated with better prognosis. Therefore, our aim was to create a risk score predicting ICU admission in adults with encephalitis, which could aid in optimal management and resource allocation. We initially identified variables that would be most predictive of ICU admission among 372 patients with encephalitis from two hospital systems in Houston, Texas (cohort 1), who met the International Encephalitis Consortium (IEC) criteria from 2005 to 2023. Subsequently, we used a binary logistic regression model to create a risk score for ICU admission, which we then validated externally using a separate cohort of patients from two hospitals in Baltimore, Maryland (cohort 2), who met the IEC criteria from 2006 to 2022. Of 634 patients with encephalitis, 255 (40%) were admitted to the ICU, including 45 of 113 (39.8%) patients with an autoimmune cause, 100 of 272 (36.7%) with an infectious cause, and 110 of 249 (44.1%) with an unknown cause (p = 0.225). After conducting a multivariate analysis in cohort 1, we found that the presence of focal neurological signs, new-onset seizure, a Full Outline of Unresponsiveness score ≤ 14, leukocytosis, and a history of chronic kidney disease at admission were associated with an increased risk of ICU admission. The resultant clinical score for predicting ICU admission had an area under the receiver operating characteristic curve (AUROC) of 0.77 (95% confidence interval [CI] 0.72-0.82, p < 0.001). Patients were classified into three risk categories for ICU admission: low risk (score 0, 12.5%), intermediate risk (scores 1-5, 49.5%), and high risk (scores 6-8, 87.5%). External validation in cohort 2 yielded an AUROC of 0.76 (95% CI 0.69-0.83, p < 0.001). ICU admission is common in patients with encephalitis, regardless of etiology. Our risk score, encompassing neurologic and systemic factors, may aid physicians in decisions regarding intensity of care for adult patients with encephalitis upon hospital admission.
Sections du résumé
BACKGROUND
BACKGROUND
Timely intensive care unit (ICU) admission for patients with encephalitis is associated with better prognosis. Therefore, our aim was to create a risk score predicting ICU admission in adults with encephalitis, which could aid in optimal management and resource allocation.
METHODS
METHODS
We initially identified variables that would be most predictive of ICU admission among 372 patients with encephalitis from two hospital systems in Houston, Texas (cohort 1), who met the International Encephalitis Consortium (IEC) criteria from 2005 to 2023. Subsequently, we used a binary logistic regression model to create a risk score for ICU admission, which we then validated externally using a separate cohort of patients from two hospitals in Baltimore, Maryland (cohort 2), who met the IEC criteria from 2006 to 2022.
RESULTS
RESULTS
Of 634 patients with encephalitis, 255 (40%) were admitted to the ICU, including 45 of 113 (39.8%) patients with an autoimmune cause, 100 of 272 (36.7%) with an infectious cause, and 110 of 249 (44.1%) with an unknown cause (p = 0.225). After conducting a multivariate analysis in cohort 1, we found that the presence of focal neurological signs, new-onset seizure, a Full Outline of Unresponsiveness score ≤ 14, leukocytosis, and a history of chronic kidney disease at admission were associated with an increased risk of ICU admission. The resultant clinical score for predicting ICU admission had an area under the receiver operating characteristic curve (AUROC) of 0.77 (95% confidence interval [CI] 0.72-0.82, p < 0.001). Patients were classified into three risk categories for ICU admission: low risk (score 0, 12.5%), intermediate risk (scores 1-5, 49.5%), and high risk (scores 6-8, 87.5%). External validation in cohort 2 yielded an AUROC of 0.76 (95% CI 0.69-0.83, p < 0.001).
CONCLUSIONS
CONCLUSIONS
ICU admission is common in patients with encephalitis, regardless of etiology. Our risk score, encompassing neurologic and systemic factors, may aid physicians in decisions regarding intensity of care for adult patients with encephalitis upon hospital admission.
Identifiants
pubmed: 39085505
doi: 10.1007/s12028-024-02063-6
pii: 10.1007/s12028-024-02063-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.
Références
Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al.; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57(8):1114–28.
Bloch KC, Glaser C, Gaston D, Venkatesan A. State of the art: acute encephalitis. Clin Infect Dis. 2023;77(5):e14-33.
doi: 10.1093/cid/ciad306
pubmed: 37485952
Venkatesan A, Habis R, Geocadin RG. Approach to acute encephalitis in the intensive care unit. Curr Opin Crit Care. 2023;29(2):89–98.
doi: 10.1097/MCC.0000000000001028
pubmed: 36794940
Sonneville R, Gault N, De Montmollin E, Klein IF, Mariotte E, Chemam S, et al. Clinical spectrum and outcomes of patients with encephalitis requiring intensive care. Eur J Neurol. 2015;22(1):6–16.
doi: 10.1111/ene.12541
pubmed: 25174376
Ali F, Wijdicks EF. Treatment of movement disorder emergencies in autoimmune encephalitis in the neurosciences ICU. Neurocrit Care. 2020;32(1):286–94.
doi: 10.1007/s12028-019-00875-5
pubmed: 31732848
Feng G, Zhou L, Li F, Hu Y, Wang X, Tian X. Predictors of outcome in clinically diagnosed viral encephalitis patients: a 5-year prospective study. BioMed Res Int. 2020;2020:2832418.
doi: 10.1155/2020/2832418
pubmed: 32724798
pmcid: 7366193
Sonneville R, de Montmollin E, Contou D, Ferrer R, Gurjar M, Klouche K, et al.; EURECA Investigator Study Group. Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort study. Intensive Care Med. 2023;49(5):517–29.
Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Ann Neurol. 2005;58(4):585–93.
doi: 10.1002/ana.20611
pubmed: 16178024
Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47(4):458–72.
doi: 10.1002/bimj.200410135
pubmed: 16161804
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensiv Care Med. 1996;22(7):707–10.
doi: 10.1007/BF01709751
Grissom CK, Brown SM, Kuttler KG, Boltax JP, Jones J, Jephson AR, et al. A modified sequential organ failure assessment score for critical care triage. Disaster Med Public Health Prep. 2010;4(4):277–84.
doi: 10.1001/dmp.2010.40
pubmed: 21149228
Madan A. Correlation between the levels of SpO
doi: 10.4103/lungindia.lungindia_106_17
pubmed: 28474668
pmcid: 5427770
Groenwold RH, Donders AR, Roes KC, Harrell FE Jr, Moons KG. Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol. 2012;175(3):210–7.
doi: 10.1093/aje/kwr302
pubmed: 22262640
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015;13(1):1.
doi: 10.1186/s12916-014-0241-z
pubmed: 25563062
pmcid: 4284921
Fillatre P, Mailles A, Stahl JP, Tattevin P, Abgrall S, Argaud L, et al.; Scientific Committee and Investigators Group. Characteristics, management, and outcomes of patients with infectious encephalitis requiring intensive care: a prospective multicentre observational study. J Crit Care. 2023;77:154300.
Thakur KT, Motta M, Asemota AO, Kirsch HL, Benavides DR, Schneider EB, et al. Predictors of outcome in acute encephalitis. Neurology. 2013;81(9):793–800.
doi: 10.1212/WNL.0b013e3182a2cc6d
pubmed: 23892708
pmcid: 3908458
Cohen J, Sotoca J, Gandhi S, Yeshokumar AK, Gordon-Lipkin E, Geocadin RG, et al. Autoimmune encephalitis: a costly condition. Neurology. 2019;92(9):e964–72.
doi: 10.1212/WNL.0000000000006990
pubmed: 30674590
Cardona M, Dobler CC, Koreshe E, Heyland DK, Nguyen RH, Sim JP, et al. A catalogue of tools and variables from crisis and routine care to support decision-making about allocation of intensive care beds and ventilator treatment during pandemics: scoping review. J Crit Care. 2021;66:33–43.
doi: 10.1016/j.jcrc.2021.08.001
pubmed: 34438132
St-Louis E, Iqbal S, Feldman LS, Sudarshan M, Deckelbaum DL, Razek TS, et al. Using the age-adjusted Charlson comorbidity index to predict outcomes in emergency general surgery. J Trauma Acute Care Surg. 2015;78(2):318–23.
doi: 10.1097/TA.0000000000000457
pubmed: 25757117
Zhan YF, Li F, Wu LC, Li JM, Zhu CY, Han MS, et al. Role of Charlson comorbidity index in predicting the ICU admission in patients with thoracic aortic aneurysm undergoing surgery. J Orthop Surg Res. 2023;18(1):870.
doi: 10.1186/s13018-023-04364-6
pubmed: 37968686
pmcid: 10652551
Argun Barış S, Boyacı H, Akhan S, Mutlu B, Deniz M, Başyiğit İ. Charlson comorbidity index in predicting poor clinical outcomes and mortality in patients with COVID-19. Turk Thorac J. 2022;23(2):145–53.
doi: 10.5152/TurkThoracJ.2022.21076
pubmed: 35404247
pmcid: 9449884
Harutyunyan G, Hauer L, Dünser MW, Karamyan A, Moser T, Pikija S, et al. Autoimmune encephalitis at the neurological intensive care unit: etiologies, reasons for admission and survival. Neurocrit Care. 2017;27(1):82–9.
doi: 10.1007/s12028-016-0370-7
pubmed: 28028790
Diaz-Arias LA, Pardo CA, Probasco JC. Autoimmune encephalitis in the intensive care unit. In: Nelson S, Nyquist P, editors. Neurointensive care unit. Cham: Springer; 2020. p. 249–63.
doi: 10.1007/978-3-030-36548-6_17
Sonneville R, Jaquet P, Vellieux G, de Montmollin E, Visseaux B. Intensive care management of patients with viral encephalitis. Rev Neurol (Paris). 2022;178(1–2):48–56.
doi: 10.1016/j.neurol.2021.12.002
pubmed: 34973832
Akavipat P, Sookplung P, Kaewsingha P, Maunsaiyat P. Prediction of discharge outcome with the full outline of unresponsiveness (FOUR) score in neurosurgical patients. Acta Med Okayama. 2011;65(3):205–10.
pubmed: 21709719
Iyer VN, Mandrekar JN, Danielson RD, Zubkov AY, Elmer JL, Wijdicks EF. Validity of the FOUR score coma scale in the medical intensive care unit. Mayo Clin Proc. 2009;84(8):694–701.
doi: 10.4065/84.8.694
pubmed: 19648386
pmcid: 2719522
Chakraverty R, Davidson S, Peggs K, Stross P, Garrard C, Littlewood TJ. The incidence and cause of coagulopathies in an intensive care population. Br J Haematol. 1996;93(2):460–3.
doi: 10.1046/j.1365-2141.1996.5101050.x
pubmed: 8639449
Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology. 2015;84(4):359–66.
doi: 10.1212/WNL.0000000000001190
pubmed: 25540320
Hansen MA, Samannodi MS, Hasbun R. Predicting inpatient mortality among encephalitis patients: a novel admission risk score. Open Forum Infect Dis. 2020;7(11):ofaa471.
doi: 10.1093/ofid/ofaa471
pubmed: 33204757
pmcid: 7651585
Sonar SA, Lal G. Blood-brain barrier and its function during inflammation and autoimmunity. J Leukoc Biol. 2018;103(5):839–53.
doi: 10.1002/JLB.1RU1117-428R
pubmed: 29431873
Wesselingh R, Butzkueven H, Buzzard K, Tarlinton D, O’Brien TJ, Monif M. Innate immunity in the central nervous system: a missing piece of the autoimmune encephalitis puzzle? Front Immunol. 2019;10:2066.
doi: 10.3389/fimmu.2019.02066
pubmed: 31552027
pmcid: 6746826
Michael BD, Griffiths MJ, Granerod J, Brown D, Davies NW, Borrow R, et al. Characteristic cytokine and chemokine profiles in encephalitis of infectious, immune-mediated, and unknown aetiology. PLoS ONE. 2016;11(1):e0146288.
doi: 10.1371/journal.pone.0146288
pubmed: 26808276
pmcid: 4726626
Mei Y, Yang J, Yuan Y, Liu Y, Liu X, Li M, et al. Systemic inflammation index values are associated with worsened disease severity and poor response to autoimmune encephalitis treatment. Front Neurol. 2021;12:709553.
doi: 10.3389/fneur.2021.709553
pubmed: 34675864
pmcid: 8523674
Terrone G, Frigerio F, Balosso S, Ravizza T, Vezzani A. Inflammation and reactive oxygen species in status epilepticus: biomarkers and implications for therapy. Epilepsy Behav. 2019;101(Pt B):106275.
doi: 10.1016/j.yebeh.2019.04.028
pubmed: 31171434
Hodgson LE, Sarnowski A, Roderick PJ, Dimitrov BD, Venn RM, Forni LG. Systematic review of prognostic prediction models for acute kidney injury (AKI) in general hospital populations. BMJ Open. 2017;7(9):e016591.
doi: 10.1136/bmjopen-2017-016591
pubmed: 28963291
pmcid: 5623486
Carod-Artal FJ. Infectious diseases causing autonomic dysfunction. Clin Auton Res. 2018;28(1):67–81.
doi: 10.1007/s10286-017-0452-4
pubmed: 28730326
Halperin JJ. Diagnosis and management of acute encephalitis. Handb Clin Neurol. 2017;140:337–47.
doi: 10.1016/B978-0-444-63600-3.00018-0
pubmed: 28187808
He J, Lian Y. Clinical study of autonomic dysfunction in patients with autoimmune encephalitis. Immunobiology. 2023;228(5):152711.
doi: 10.1016/j.imbio.2023.152711
pubmed: 37543010
Fidalgo P, Bagshaw SM. Chronic kidney disease in the intensive care unit. In: Arici M, editor. Management of chronic kidney disease. Berlin: Springer; 2014. p. 417–38.
doi: 10.1007/978-3-642-54637-2_32
Wang B, Wang C, Feng J, Hao M, Guo S. Clinical features, treatment, and prognostic factors in neuronal surface antibody-mediated severe autoimmune encephalitis. Front Immunol. 2022;13:890656.
doi: 10.3389/fimmu.2022.890656
pubmed: 35720290
pmcid: 9205246